Trisalus reiterates 2026 revenue guidance of $54M-$57M as CMS G-code expands TriNav reimbursement into office-based labs

RegulatoryTriNavPositive

AI Analysis

Summary

Trisalus reiterates its 2026 revenue guidance of $54M-$57M as a CMS G-code expansion broadens TriNav reimbursement coverage to office-based laboratories.

Financial Highlights

Guidance

$54M-$57M for 2026

Outcome Details

CMS G-code expansion enabling TriNav reimbursement in office-based labs

Importance:6/10

Sentiment:

0.60

reimbursementCMSG-coderevenue guidanceoffice-based labs

Related Companies

$TLSIW

Read the original article

Published by Seeking Alpha Healthcare on August 7, 2026 2:04 AM

Read Original